These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25339504)

  • 21. Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide.
    Heublein DM; Huntley BK; Boerrigter G; Cataliotti A; Sandberg SM; Redfield MM; Burnett JC
    Hypertension; 2007 May; 49(5):1114-9. PubMed ID: 17372040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutting Edge of Brain Natriuretic Peptide (BNP) Research　- The Diversity of BNP Immunoreactivity and Its Clinical Relevance.
    Kuwahara K; Nakagawa Y; Nishikimi T
    Circ J; 2018 Sep; 82(10):2455-2461. PubMed ID: 30135320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant Soluble Corin Improves Cardiac Function in Mouse Models of Heart Failure.
    Niu Y; Zhang S; Gu X; Zhou T; Li F; Liu M; Wu Q; Dong N
    J Am Heart Assoc; 2021 Apr; 10(7):e019961. PubMed ID: 33759549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
    PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload.
    Pemberton CJ; Yandle TG; Rademaker MT; Charles CJ; Aitken GD; Espiner EA
    Am J Physiol; 1998 Oct; 275(4):H1200-8. PubMed ID: 9746467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
    Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-type natriuretic peptide forms within the heart, coronary sinus, and peripheral circulation in humans: evidence for degradation before secretion.
    Mahagamasekera PG; Ruygrok PN; Palmer SC; Richards AM; Ansell GS; Nicholls MG; Pemberton CJ; Lewis LK; Yandle TG
    Clin Chem; 2014 Mar; 60(3):549-58. PubMed ID: 24415740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart is the Target Organ of Endogenous Cardiac Natriuretic Peptides.
    Tsutamoto T; Sakai H; Yamamoto T; Nakagawa Y
    Int Heart J; 2020 Jan; 61(1):77-82. PubMed ID: 31956150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
    Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
    Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
    Halfinger B; Hammerer-Lercher A; Amplatz B; Sarg B; Kremser L; Lindner HH
    Clin Chem; 2017 Jan; 63(1):359-368. PubMed ID: 28062629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-18 stimulates B-type natriuretic peptide synthesis by cardiomyocytes in vitro and its plasma levels correlate with B-type natriuretic peptide in non-overloaded acute heart failure patients.
    Di Somma S; Pittoni V; Raffa S; Magrini L; Gagliano G; Marino R; Nobili V; Torrisi MR
    Eur Heart J Acute Cardiovasc Care; 2017 Aug; 6(5):450-461. PubMed ID: 24585936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The virtually mature B-type natriuretic peptide (BNP1-32) is a precursor for the more effective BNP1-30.
    Schwiebs A; Wang Y; Moore AM; Zhu X; Pankow K; Siems WE; Walther T
    Br J Pharmacol; 2020 Mar; 177(6):1424-1433. PubMed ID: 31691951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemistry of B-type natriuretic peptide--where are we now?
    Mair J
    Clin Chem Lab Med; 2008; 46(11):1507-14. PubMed ID: 18842106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.
    Lainchbury JG; Campbell E; Frampton CM; Yandle TG; Nicholls MG; Richards AM
    J Am Coll Cardiol; 2003 Aug; 42(4):728-35. PubMed ID: 12932611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure--different proBNP-108 to BNP-32 ratios in atrial and ventricular overload.
    Nishikimi T; Minamino N; Ikeda M; Takeda Y; Tadokoro K; Shibasaki I; Fukuda H; Horiuchi Y; Oikawa S; Ieiri T; Matsubara M; Ishimitsu T
    Heart; 2010 Mar; 96(6):432-9. PubMed ID: 19966110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse molecular forms of plasma B-type natriuretic peptide in heart failure.
    Nishikimi T; Minamino N; Nakao K
    Curr Heart Fail Rep; 2011 Jun; 8(2):140-6. PubMed ID: 21340670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes.
    Peng J; Jiang J; Wang W; Qi X; Sun XL; Wu Q
    Biochem Biophys Res Commun; 2011 Aug; 411(3):593-8. PubMed ID: 21763278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.